An optimal window of platelet reactivity by LTA assay for patients undergoing percutaneous coronary intervention.
Jing WangJing WangZhou DongJiazheng MaJianzhen TengTong WangXiaofeng ZhangQian GuZekang YeInam UllahChuchu TanSamee AbdusLu ShiXiaoxuan GongChunjian LiPublished in: Thrombosis journal (2021)
Trial registration number: ClinicalTrials.gov NCT01968499 . Registered 18 October 2013 - Retrospectively registered.
Keyphrases
- percutaneous coronary intervention
- patients undergoing
- st segment elevation myocardial infarction
- acute coronary syndrome
- acute myocardial infarction
- coronary artery disease
- st elevation myocardial infarction
- study protocol
- antiplatelet therapy
- phase iii
- coronary artery bypass grafting
- high throughput
- clinical trial
- phase ii
- atrial fibrillation
- randomized controlled trial
- coronary artery bypass
- open label